Everolimus in heavily pretreated metastatic breast cancer: Is real world experience different?
Journal:
Indian journal of cancer
Published Date:
Jan 1, 2016
Abstract
BACKGROUND: Drugs targeting mammalian target of rapamycin signaling pathway have been recently approved for treatment of hormone receptor (HR) positive metastatic breast cancer (MBC). However, there is lack of real world data from India on the use of this therapeutic strategy.